Literature DB >> 8314082

Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene.

A C Karaplis1, A Luz, J Glowacki, R T Bronson, V L Tybulewicz, H M Kronenberg, R C Mulligan.   

Abstract

The parathyroid hormone-related peptide (PTHrP) gene was disrupted in murine embryonic stem cells by homologous recombination, and the null allele was introduced into the mouse germ line. Mice homozygous for the PTHrP null mutation died postnatally, probably from asphyxia, and exhibited widespread abnormalities of endochondral bone development. Histological examination revealed a diminution of chondrocyte proliferation, associated with premature maturation of chondrocytes and accelerated bone formation. Analysis of earlier developmental stages revealed that disturbance in cartilage growth preceded abnormal endochondral bone formation. There were no morphological abnormalities apparent in other tissues. These results provide direct evidence implicating PTHrP in normal skeletal development and serve to emphasize its potential involvement in human osteochondrodysplasias.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8314082     DOI: 10.1101/gad.8.3.277

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  232 in total

1.  Chondrogenesis just ain't what it used to be.

Authors:  G Karsenty
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

Review 2.  Interaction of PTH and PTHrP with their receptors.

Authors:  T J Gardella; H Jüppner
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

Review 3.  Parathyroid hormone-related protein.

Authors:  R A Nissenson
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

Review 4.  PTH and PTHrP effects on the skeleton.

Authors:  A C Karaplis; D Goltzman
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

Review 5.  Growth regulatory factors and bone.

Authors:  G R Mundy; D Chen; M Zhao; S Dallas; C Xu; S Harris
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

6.  TGFbeta and PTHrP control chondrocyte proliferation by activating cyclin D1 expression.

Authors:  F Beier; Z Ali; D Mok; A C Taylor; T Leask; C Albanese; R G Pestell; P LuValle
Journal:  Mol Biol Cell       Date:  2001-12       Impact factor: 4.138

7.  A case of parathyroid hormone-related peptide producing gallbladder carcinoma and establishment of a cell line, PTHrP-GBK.

Authors:  Hirotoshi Ebinuma; Hiroyuki Imaeda; Yukiko Fukuda; Shingo Miyaguchi; Toshiyuki Yasui; Tatsuo Hoshino; Takashi Okamura; Rokuro Ariwa; Hidetsugu Saito
Journal:  Dig Dis Sci       Date:  2002-01       Impact factor: 3.199

8.  Local and systemic control of the osteoblast.

Authors:  G J Strewler
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

Review 9.  The PTH/PTHrP receptor in Jansen's metaphyseal chondrodysplasia.

Authors:  L M Calvi; E Schipani
Journal:  J Endocrinol Invest       Date:  2000-09       Impact factor: 4.256

10.  PTHrP 1-141 and 1-86 increase in vitro bone formation.

Authors:  Blake Eason Hildreth; Jillian L Werbeck; Nandu K Thudi; Xiyun Deng; Thomas J Rosol; Ramiro E Toribio
Journal:  J Surg Res       Date:  2010-03-16       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.